Single local instillation of Staphylococcus aureus peptidoglycan prevents diabetes-induced impaired wound healing

Wound Repair and Regeneration

Volumn 6, Issue 5, 1998, Pages 449-456

  Qiu, Jian G ^a   Chang, Tsueng H ^a   Steinberg, Jacob J ^a   Levenson, Stanley M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDOGLYCAN; STREPTOZOCIN;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; DRUG INSTILLATION; EXPERIMENTAL DIABETES MELLITUS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTHESES AND ORTHOSES; RANDOMIZATION; RAT; REFERENCE VALUE; SPRAGUE DAWLEY RAT; STAPHYLOCOCCUS AUREUS; SURGICAL SPONGE; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; INSTILLATION, DRUG; MALE; PEPTIDOGLYCAN; PROSTHESES AND IMPLANTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; STAPHYLOCOCCUS AUREUS; STREPTOZOCIN; SURGICAL SPONGES; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

EID: 0032149973     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.1998.60507.x     Document Type: Article

References (57)

1. Morain WD, Colen LB. Wound healing in diabetes mellitus. Clin Plast Surg 1990;17:493-501.
2. Goodson WH III, Hunt TK. Wound healing and the diabetic patient. Surg Gynecol Obstet 1979;149:600-8.
3. Goodson WH III, Hunt TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res 1977;22:221-7.
4. Yue DK, McLennan S, Marsh M, Mai YW, Spalviero J, Delbridge L, Reeve T, Turtel JR. Effects of experimental diabetes, uremia, and malnutrition on wound healing. Diabetes 1987;36:295-9.
5. Nagy S, Redei A, Karagy S. Studies on granulation tissue production in alloxan-diabetic rats. J Endocrinol 1961;22:143-6.
6. Prakash A, Pandit PN, Sharma LK. Studies of wound healing in experimental diabetes. Int Surg 1974;59:25-8.
7. Schneir M, Imberman M, Golub L, Ramamurthy N. Dietary ascorbic acid increases collagen production in skin of streptozotocin-induced diabetic rats by normalizing ribosomal efficiency. Ann NY Acad Sci 1987;498:514-6.
8. Weringer EJ, Kelso JM, Tamal R, Arquilla ER. Effects of insulin on wound healing in diabetic mice. Acta Endocrinol 1982;99:101-8.
9. Greenwald DP, Shumway S, Zachary LS, LaBarbera M, Albear P, Temaner M, Gottlieb LJ. Endogenous verus toxin-induced diabetes in rats: a mechanical comparison of two skin wound-healing models. Plast Reconstr Surg 1993;91:1087-92.
10. Covington DS, Xue H, Pizzini R, Lally KP, Andrassy RJ. Streptozotocin and alloxan are comparable agents in the diabetic model of impaired wound healing. Diabetes Res 1993;23:47-53.
11. Levenson SM, Kan-Gruber D, Gruber C, Molnar J, Seifter E. Wound healing accelerated by Staphylococcus aureus. Arch Surg 1983;118:310-20.
12. Levenson SM, Chang TH, Kan-Gruber D, Gruber C, Steinberg JJ, Liu X, Watford A, Freundlich L, Rojkind M. Accelerating effects of non-viable Staphylococcus aureus, its cell wall, and cell wall peptidoglycan. Wound Rep Reg 1996;4:461-9.
13. Kilcullen J, Ly Q, Chang TH, Levenson SM, Steinberg JJ. Non-viable Staphylococcus aureus and its peptidoglycan stimulate macrophage recruitment, angiogenesis, fibroplasia and collagen accumulation in wounded rats. Wound Rep Reg 1998;6:149-156.
14. Chang TH, Patel M, Watford A, Freundlich L, Steinberg JJ, Levenson SM. Single local instillation of nonviable Staphylococcus aureus or its peptidoglycan ameliorates glucocorticoid-induced impaired wound healing. Wound Rep Reg 1997;5:184-90:
15. Imegwu O, Chang TH, Steinberg JJ, Levenson SM. Staphylococcus aureus peptidoglycan ameliorates cyclophosphamide-induced impairment of wound healing. Wound Rep Reg 1997;5:364-72.
16. Park JT, Hancock R. A fractionation procedure for studies of the synthesis of cell-wall mucopeptide and of other polymers in cells of Staphylococcus aureus. J Gen Microbiol 1960;22:249-58.
17. Levenson SM, Crowley LV, Geever EF, Rosen H, Berard CW. Some studies on wound healing: experimental methods, effect of ascorbic acid and effect of deuterium oxide. J Trauma 1964;4:543-66.
18. Levenson SM, Geever EF, Crowley LV, Oates JF, Berard CW, Rosen H. The healing of rat skin wounds. Ann Surg 1965;161:293-308.
19. Woessner JF. Determination of hydroxyproline in connective tissues. In: Hall DA, editor. The methodology of connective tissue research. Oxford: Jaynson-Bruvyers, 1976:227-33.
20. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in genetically diabetic mouse. Am J Pathol 1990;136:1235-46.
21. Fahey TJ, Sadaty A, Jones WG, Barber A, Smoller B, Shires GT. Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991;50:308-13.
22. Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med 1990;172:245-51.
23. Seifter E, Rettura G, Padawer J, Stratford F, Kambosos D, Levenson SM. Impaired wound healing in streptozotocin diabetes: prevention by supplemental vitamin A. Ann Surg 1981;194:42-50.
24. Andreassen TT, Oxlund H. The influence of experimental diabetes and insulin treatments on the biochemical properties of rat skin incisional wounds. Acta Chir Scand 1987;153:405-9.
25. Lien YH, Stern R, Fu JC, Siegel RC. Inhibition of collagen fibril formation in vitro and subsequent cross-linking by glucose. Science 1984;225:1489-91.
26. Davidson JM, Broadley KN, Quaglino D Jr. Reversal of the wound healing deficit in diabetic rats by combined basic fibroblast growth factor and transforming growth factor-β1 therapy. Wound Rep Reg 1997;5:77-88.
27. Goodson WH III, Hunt TK. Wound collagen accumulation in obese hyperglycemic mice. Diabetes 1986;35:491-5.
28. Schneir J, Ramamurthy N, Golub L. Skin collagen metabolism in the streptozotocin-induced diabetic rat: enhanced catabolism of collagen formed both before and during the diabetic state. Diabetes 1982;31:426-31.
29. Bowersox JC. In vivo collagen metabolism in spontaneously diabetic (db/db) mice. Exp Mol Pathol 1986;45:221-6.
30. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986;232:1629-32.
31. Black CT, Hennessey PJ, Ford EG, Andrassy RJ. Protein glycosylation and collagen metabolism in normal and diabetic rats. J Surg Res 1989;47:200-2.
32. Hennessey PJ, Ford EG, Black CT, Andrassy RJ. Wound collagenase activity correlates directly with collagen glycosylation in diabetic rats. J Pediatr Surg 1990;25:75-8.
33. Bitar MS, Labbad ZN. Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J Surg Res 1996;61:113-9.
34. Bitar MS. Insulin-like-growth factor-1 reverses diabetes-induced wound healing impairment in rats. Horm Metab Res 1997;29:383-6.
35. Zimbler AG, Mills CD, Caldwell MD. Effect of diabetic rat wound fluid on fibroblast growth. Surg Forum 1988;39:629-32.
36. Spanheimer RG. Direct inhibition of collagen production in vitro by diabetic rat serum. Metab Clin Exp 1988;37:479-85.
37. Verhofstad MHJ, Hendriks T. Complete prevention of impaired anastomotic healing in diabetic rats requires pre-operative blood glucose control. Br J Surg 1996;83:1717-21.
38. Hehenberger K, Hansson A. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem Funct 1997;15:197-201.
39. Grotendorst GR, Martin GR, Pencev D, Sodek J, Harvey AK. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 1985;76:2323-9.
40. Hennessey PJ, Black CT, Andrassy RJ. Epidermal growth factor and insulin act synergistically during diabetic healing. Arch Surg 1990;125:926-9.
41. Hennessey PJ, Black CT, Andrassy RJ. EGF increases short-term type 1 collagen accumulation during wound healing in diabetic rats. J Pediatr Surg 1990;25:893-7.
42. Phillips LG, Abdullah KM, Geldner PD, Dobbins S, Ko F, Linares HA, Broemeling LD, Robson MC. Application of fibroblast growth factor may reverse diabetic wound healing impairment. Ann Plast Surg 1993;31:331-4.
43. Okumura M, Okuda T, Nakamura T, Yajima M. Effect of basic fibroblast growth factor on wound healing in healing-impaired animal models. Arzneimettelforschung 1996;46:547-51.
44. Chitra P, Sajithlal GB, Chandralkasson G. Influence of aloe vera in the healing of dermal wounds in diabetic rats. J Ethnopharmacol 1998;59:195-201.
45. Kotani S, Watanabe Y, Shimona T, Marita T, Kato K. Immunoadjuvant activities of cell walls, their water-soluble franctions and peptidoglycan subunits prepared from various gram-positive bacteria and of synthetic N-acetylmuramyl peptides. Z Immunitatsforsch Exp Klin Immunol 1975;149:302-19.
46. Seidel PH, Schleifer KH, editors. Biological properties of peptidoglycan. Berlin: DeGruyter, 1986.
47. Schleifer KH. Chemical structure of peptidoglycan, its modifiability, and relation to biological activity. Immuno-Forsch Bd 1975;149:S104-17.
48. Dziarski R. Effects of peptidoglycan on the cellular components of the immune system. In: Seidel PH, Schleifer KH, editors. Biological properties of peptidoglycan. Berlin: DeGryter, 1986:229-47.
49. Riber U, Espersen F, Wilkinson BJ, Kharazmi A. Neutrophil chemotactic activity of peptidoglycan: a comparison between Staphylococcus aureus and Staphylococcus epidermidis. APMIS 1990;98:881-6.
50. Jupin C, Parant M, Chedid L, Damais C. Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides. Inflammation 1987;11:153-61.
51. Dziarski R. Correlation between ribosylation of pertussis toxin substrates and inhibition of peptidoglycan muramyl dipeptide and lipopolysaccharide-induced mitogenic stimulation in B lymphocytes. Eur J Immunol 1989;19:125-30.
52. Keller R, Gehri R, Keist R, Huf E, Kayser FH. The interaction of macrophages and bacteria: a comparative study of the induction of tumoricidal activity and of reactive nitrogen intermediates. Cell Immunol 1991;134:249-56.
53. Lafyatis R, Thompson NL, Remmers EF, Flanders KC, Roche NS, Kim SJ, Case JP, Sporn MP, Roberts AB, Wilder RL. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats: studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol 1989;143:1142-8.
54. Rye M, Rotta J, Straka R, Zaoral M, Jezek J, Farkas J, Krchnack V. Blood-platelets-damaging activity of some synthetic streptococcus peptidoglycan subunits and analoques. Zentralbl Bakeriol Microbiol Hyg (A) 1987;263:577-84.
55. Vacheron F, Guenounou M, Zinbi H, Nauciol C. Release of a cytotoxic factor by macrophages stimulated with adjuvant active peptidoglycans. J Natl Cancer Inst 1986;77:549-53.
56. Liu X, Levenson SM, Chang TH, Steinberg JJ, Imegwu O, Rojkind M. Molecular mechanisms underlying wound healing acceleration by Staphylococcus aureus peptidoglyan. Wound Rep Reg 1996;4:470-6.
57. Liu X, Chang TH, Levenson SM, Rojkind M. Wound fluids from saline solution- and Staphylococcus aureus peptidoglycan-inoculated sponges induce expression of matrix metalloproteinase 13 messenger ribonucleic acid by cultured rat fibroblast. Wound Rep Reg 1997;5:348-54.